Margo R. Roberts, Chief Scientific Officer at Kite Pharma, Inc. (KITE), sold 2,618 shares at $52.49 ($145K) on 2016-01-15, disclosed to the SEC on 2016-01-19.
Open-market sale of $145k KITE by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.49 | 264 | $14K | 9.6% |
| 2 | $53.95 | 700 | $38K | 26.1% |
| 3 | $55.83 | 1,054 | $59K | 40.6% |
| 4 | $56.90 | 400 | $23K | 15.7% |
| 5 | $57.73 | 200 | $12K | 8.0% |
| Total | $55.30 avg | 2,618 |
| $145K |
| 100% |
| Filing → |
| KITE | SELL | 2016-02-16 | $1.2M | — | Filing → |
| KITE | SELL | 2015-12-17 | $392K | — | Filing → |
| KITE | SELL | 2015-11-18 | $480K | — | Filing → |